What is Ion Beam Applications SA?
Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally.
IOBCF · Verdict
Solid reward · elevated risk
IOBCF stands out on valuation and growth, but watch the profitability signal.
Based on 88% data coverage
IOBCF · Verdict
P/E 6.4×
Rev +16.8% CAGR · earnings +33.6%
Interest covered 7.0×
2% net margin · 16% ROE
-4% free-cash-flow margin
Below average
Model-based scoring. For information only — not financial advice.
Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally. It operates through Proton Therapy and Other Accelerators; and Dosimetry segments. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 557.72M, and a P/E ratio of 27.9x.
The scoring profile indicates moderate reward potential, with valuation and growth as the leading contributors. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.